Enterohemorrhagic and other Shigatoxin-producing Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 164

Murray, M.D., Brater, D.C., 1993. Renal toxicity of the nonsteroidal anti-inlammatory drugs.
Annu. Rev. Pharmacol. Toxicol. 33, 435-465 .
Nadler, C., Baruch, K., Kobi, S., et al., 2010. The type III secretion effector NleE inhibits NF-kappaB
activation. PLoS Pathog. 6 (1), e1000743 .
Nagai, T., Abe, A., Sasakawa, C., 2005. Targeting of enteropathogenic Escherichia coli EspF to host
mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in
EspF. J. Biol. Chem. 280 (4), 2998-3011 .
Nataro, J.P., Kaper, J.B., 1998. Diarrheagenic Escherichia coli . Clin. Microbiol. Rev. 11 (1), 142-201 .
Nathanson, S., Kwon, T., Elmaleh, M., et al., 2010. Acute neurological involvement in diarrhea-
associated hemolytic uremic syndrome. Clin. J. Am. Soc. Nephrol. 5 (7), 1218-1228 .
Naylor, S.W., Low, J.C., Besser, T.E., et al., 2003. Lymphoid follicle-dense mucosa at the terminal
rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in
the bovine host. Infect. Immun. 71 (3), 1505-1512 .
Nevard, C.H., Jurd, K.M., Lane, D.A., et al., 1997. Activation of coagulation and ibrinolysis in
childhood diarrhoea-associated haemolytic uraemic syndrome. Thromb. Haemost. 78 (6),
1450-1455 .
Newton, H.J., Pearson, J.S., Badea, L., et al., 2010. The type III effectors NleE and NleB from
enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB
p65. PLoS Pathog. 6 (5), e1000898 .
Newton, H.J., Sloan, J., Bulach, D.M., et al., 2009. Shiga toxin-producing Escherichia coli strains
negative for locus of enterocyte effacement. Emerg. Infect. Dis. 15 (3), 372-380 .
Nguyen, L.T., Gillespie, B.E., Nam, H.M., et al., 2004. Detection of Escherichia coli O157:H7 and
Listeria monocytogenes in beef products by real-time polymerase chain reaction. Foodborne
Pathog. Dis. 1 (4), 231-240 .
Nicholls, L., Grant, T.H., Robins-Browne, R.M., 2000. Identiication of a novel genetic locus that
is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to
epithelial cells. Mol. Microbiol. 35 (2), 275-288 .
Noris, M., Mescia, F., Remuzzi, G., 2012. STEC-HUS, atypical HUS and TTP are all diseases of
complement activation. Nat. Rev. Nephrol. 8 (11), 622-633 .
Nougayrede, J.P., Donnenberg, M.S., 2004. Enteropathogenic Escherichia coli EspF is targeted
to mitochondria and is required to initiate the mitochondrial death pathway. Cell Microbiol. 6
(11), 1097-1111 .
Nougayrede, J.P., Foster, G.H., Donnenberg, M.S., 2007. Enteropathogenic Escherichia coli
effector EspF interacts with host protein Abcf2. Cell Microbiol. 9 (3), 680-693 .
O'Brien, A.D., LaVeck, G.D., 1983. Puriication and characterization of a Shigella dysenteriae
1-like toxin produced by Escherichia coli . Infect. Immun. 40 (2), 675-683 .
Obata, F., Tohyama, K., Bonev, A.D., et al., 2008. Shiga toxin 2 affects the central nervous sys-
tem through receptor globotriaosylceramide localized to neurons. J. Infect. Dis. 198 (9),
1398-1406 .
Obrig, T.G., Karpman, D., 2012. Shiga toxin pathogenesis: kidney complications and renal failure.
Curr. Top. Microbiol. Immunol. 357, 105-136 .
Obrig, T.G., Louise, C.B., Lingwood, C.A., et al., 1993. Endothelial heterogeneity in Shiga toxin
receptors and responses. J. Biol. Chem. 268 (21), 15484-15488 .
Obrig, T.G., Moran, T.P., Brown, J.E., 1987. The mode of action of Shiga toxin on peptide
elongation of eukaryotic protein synthesis. Biochem. J. 244 (2), 287-294 .
Ogura, Y., Ooka, T., Whale, A., et al., 2007. TccP2 of O157:H7 and non-O157 enterohemorrhagic
Escherichia coli (EHEC): challenging the dogma of EHEC-induced actin polymerization.
Infect. Immun. 75 (2), 604-612 .